HaighP.I., EssnerR., WardlawJ.C., SternS.L., MortonD.L.Long-term survival after complete resection of melanoma metastatic to the adrenal gland.Ann Surg Oncol1999; 6: 633–9
2.
LamK.Y., LoC.Y.Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital.Clin Endocrinol (Oxf)2002; 56: 95–101
3.
BrownM.J., DolleryC.T.A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.Br J Clin Pharmacol1981; 11: 79–83
4.
ScottR.E., WilsonD.M.Role of the clinical laboratory in the diagnosis and management of malignant melanoma.Mayo Clin Proc1989; 64: 837–45
5.
FarajB.A., LawsonD.H., NixonD.W., Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine.Clin Chem1981; 27: 108–12
6.
Dimitrakopoulou-StraussA., StraussL.G., BurgerC.Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.J Nucl Med2001; 42: 248–56
7.
Das GuptaT., BrasfieldR.Metastatic melanoma. A clinicopathological study.Cancer1964; 17: 1323–39
8.
WoodT.F., DiFronzoL.A., RoseD.M., HaighP.I., SternS.L., WanekL.et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival?Ann Surg Oncol.2001; 8: 658–62
